Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 4Not yet recruiting 2Active not recruiting 2Withdrawn 1Unknown 1Suspended 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Neuroblastoma 2Neoplasm Metastasis 2Leukemia, Myeloid, Acute 2Hodgkin Disease 2Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Oropharyngeal Neoplasms 1Myelodysplastic Syndromes 1Multiple Myeloma 1Leukemia, Myeloid 1Head and Neck Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 3naxitamab 2fludarabine phosphate 2fludarabine 2dinutuximab 2Topotecan 2Granulocyte-Macrophage Colony-Stimulating Factor 2Colony-Stimulating Factors 2sargramostim 1iberdomide 1eliglustat 1Vorinostat 1Thiotepa 1Tacrolimus 1Mycophenolic Acid 1Methotrexate 1Melphalan 1Magnetic Resonance Spectroscopy 1Isotretinoin 1Cyclosporine 1Busulfan 1Biopsy 1Antilymphocyte Serum 13-Iodobenzylguanidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Neuroblastoma × fludarabine phosphate × Clear all
NCT07358260 2026-01-22

B7-H3.CD28Z.CART in Solid Tumors

Dana-Farber Cancer Institute

Phase 1 Not yet recruiting
40 enrolled
CNS

Neuroblastoma

NCT05303727 2022-07-01

Allogeneic Hematopoietic Stem Cell Transplantation for 4/M Neuroblastoma

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Not yet recruiting
64 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡